Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Tumor suppressor protein VHL is induced at high cell density and mediates contact inhibition of cell growth

Abstract

In spite of the general recognition of von Hippel-Lindau (VHL) as a tumor suppressor gene, the physiological and pathological importance of VHL protein in cell growth regulation and tumorigenesis remains unclear. Here we show that in normal human renal proximal tubule epithelial cells (RPTEC), the steady-state amount of VHL protein is strictly regulated by cell density. The cellular VHL content is more than 100-fold higher in dense cultures than in sparse cultures. The increase in VHL protein at high cell density was also observed for NIH3T3 fibroblasts, suggesting the generality of the phenomenon. The growth rates of renal cell carcinoma cells lacking an intact VHL gene and their derivatives with wild-type or mutant VHL expression vector do not differ significantly when they are growing in log-phase. Importantly, however, there is a difference when they reach confluency: cells lacking wild-type VHL grew continuously, while cells expressing exogenous VHL protein showed relatively limited cell growth. Using an ecdysone-inducible VHL expressing cell line, we also show that the growth inhibition at high cell density can be released by attenuating the VHL expression. Taken together, we propose that VHL protein functions as a growth suppressor at high cell density, and this might be the basis of the tumor suppressor function of VHL.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 4
Figure 3
Figure 5
Figure 6
Figure 7

Similar content being viewed by others

Abbreviations

RCC:

renal cell carcinoma

SDS-PAGE:

sodium dodecyl sulfate polyacrylamide gel electrophoresis

VEGF:

vascular endothelial growth factor

VHL:

von Hippel-Lindau

References

  • Behrens J, von Kries JP, Kuhl M, Bruhn L, Wedlich D, Grosschedl R, Birchmeier W . 1996 Nature 382: 638–642

  • Blankenship C, Naglich JG, Whaley JM, Seizinger B, Kley N . 1999 Oncogene 18: 1529–1535

  • Cockman ME, Masson N, Mole DR, Jaakkola P, Chang GW, Clifford SC, Maher ER, Pugh CW, Ratcliffe PJ, Maxwell PH . 2000 J. Biol. Chem. 275: 25733–25741

  • Corless CL, Kibel AS, Iliopoulos O, Kaelin Jr WG . 1997 Hum. Pathol. 28: 459–464

  • Feng H, Zhong W, Punkosdy G, Gu S, Zhou L, Seabolt EK, Kipreos ET . 1999 Nat. Cell. Biol. 1: 486–492

  • Foster K, Prowse A, van den Berg A, Fleming S, Hulsbeek MM, Crossey PA, Richards FM, Cairns P, Affara NA, Ferguson-Smith MA, Buys CHCM, Maher E . 1994 Hum. Mol. Genet. 3: 2169–2173

  • Gao J, Naglich JG, Laidlaw J, Whaley JM, Seizinger BR, Kley N . 1995 Cancer Res. 55: 743–747

  • Gnarra JR, Tory K, Weng Y, Scmidt L, Wei MH, Li H, Latif F, Liu S, Chen F, Duh FM, Lubensky I, Duan DR, Florence C, Pozzati R, Walther, MM, Bander NH, Grossman BH, Brauch H, Pomer S, Brooks D, Isaacs WB, Lerman ML, Zbar B, Linehan WM . 1994 Nat. Genet. 7: 85–90

  • Hart M, Concordet JP, Lassot I, Albert I, del los Santos R, Durand H, Perret C, Rubinfeld B, Margottin F, Benarous R, Polakis P . 1999 Curr. Biol. 9: 207–210

  • He TC, Sparks AB, Rago C, Hermeking H, Zawel L, da Costa LT, Morin PJ, Vogelstein B, Kinzler KW . 1998 Science 281: 1509–1512

  • Hinck L, Nelson WJ, Papkoff J . 1994 J. Cell. Biol. 124: 729–741

  • Iliopoulos O, Kibel A, Gray S, Kaelin Jr WG . 1995 Nat. Med. 1: 822–826

  • Iliopoulos O. Ohh M, Kaelin Jr WG . 1998 Proc. Natl. Acad. Sci. USA 95: 11661–11666

  • Iwai K, Yamanaka K, Kamura T, Minato N, Conaway RC, Conaway JW, Klausner RD, Pause A . 1999 Proc. Natl. Acad. Sci. USA 96: 12436–12441

  • Judah F . 1995 Nat. Med. 1: 27–31

  • Kamura T, Koepp DM, Conrad MN, Skowyra D, Moreland RJ, Iliopoulos O, Lane WS, Kaelin Jr WG. Elledge SJ, Conaway RC, Harper JW, Conaway JW . 1999 Science 284: 657–661

  • Kandikonda S, Oda D, Niederman R, Sorkin BC . 1996 Cell Adhes. Commun. 4: 13–24

  • Kibel A, Iliopoulos O, DeCaprio JA, Kaelin Jr WG . 1995 Science 269: 1444–1446

  • Kim M, Katayose Y, Li Q, Rakkar AN, Li Z, Hwang SG, Katayose D, Trepel J, Cowan KH, Seth P . 1998 Biochem. Biophys. Res. Commun. 253: 672–677

  • Kitagawa M, Hatakeyama S, Shirane M, Matsumoto M, Ishida N, Hattori K, Nakamichi I, Kikuchi A, Nakayam K . 1999 EMBO J. 18: 2401–2410

  • Korinek V, Barker N, Morin PJ, van Wichen D, de Weger R, Kinzler KW, Vogelstein B, Clevers H . 1997 Science 275: 1784–1787

  • Lamiell JM, Salazar FG, Hsia YE . 1989 Medicine (Baltimore) 68: 1–29

  • Latif F, Tory K, Gnarra J, Yao M, Duh FM, Orcutt ML, Stackhouse T, Kuzmin I, Modi W, Geil L, Schmidt L, Zhou F, Li H, Wei MH, Chen F, Glenn G, Choyke P, Walther MM, Weng YR, Dean M, Glavac D, Richards FM, Crossey PA, Ferguson-Smith MA, Pasilier LD, Chumakov I, Cohen D, Chinault AC, Maher ER, Linehan WM, Zbar B, Lerman MI . 1993 Science 260: 1317–1320

  • Lee S, Chen DY, Humphrey JS, Gnarra JR, Linehan WM, Klausner RD . 1996 Proc. Natl. Acad. Sci. USA. 93: 1770–1775

  • Lehner CF, O'Farrell PH . 1989 Cell 56: 957–968

  • Liakopoulos D, Busgen T, Brychzy A, Jentsch S, Pause A . 1999 Proc. Natl. Acad. Sci. USA 96: 5510–5515

  • Lieubeau-Teillet B, Rak J, Jothy S, Iliopoulos O, Kaelin Jr WG, Kerbel RS . 1998 Cancer Res. 58: 4957–4962

  • Lisztwan J, Imbert G, Wirbelauer C, Gstaiger M, Krek W . 1999 Genes Dev. 13: 1822–1833

  • Lonergan KM, Iliopoulos O, Ohh M, Kamura T, Conaway RC, Conaway JW, Kaelin Jr WG . 1998 Mol. Cell. Biol. 18: 732–741

  • Los M, Jansen GH, Kaelin WG, Lips CJ, Blijham GH, Voest EE . 1996 Lab. Invest. 75: 231–238

  • Maxwell PH, Wiesener MS, Chang GW, Clifford SC, Vaux EC, Cockman ME, Wykoff CC, Pugh CW, Maher ER, Ratcliffe PJ . 1999 Nature 399: 271–275

  • Melmon KL, Rosen SW . 1964 Am. J. Med. 36: 595–607

  • Miyake S, Makimura M, Kanegae Y, Harada S, Sato Y, Takamori K, Tokuda C, Saito I . 1996 Proc. Natl. Acad. Sci. USA 93: 1320–1324

  • Morin PJ, Sparks AB, Korinek V, Barker N, Clevers H, Vogelstein B, Kinzler KW . 1997 Science 275: 1787–1790

  • Ohh M, Park CW, Ivan M, Hoffman MA, Kim T-Y, Huang LE, Pavletich N, Chau V, Kaelin Jr WG . 2000 Nature Cell Biol. 2: 423–427

  • Okuda H, Hirai S, Takaki Y, Kamada M, Baba M, Sakai N, Kishida T, Kaneko S, Yao M, Ohno S, Shuin T . 1999 Biochem. Biophys. Res. Commun. 263: 491–497

  • Orford K, Crockett C, Jensen JP, Weissman AM, Byers SW . 1997 J. Biol. Chem. 272: 24735–24738

  • Orford K, Orford CC, Byers SW . 1999 J. Cell Biol. 146: 855–868

  • Pal S, Claffey KP, Dvorak HF, Mukhopadhyay D . 1997 J. Biol. Chem. 272: 27509–27512

  • Pause A, Lee S, Lonergan KM, Klausner RD . 1998 Proc. Natl. Acad. Sci. USA 95: 993–998

  • Pause A, Lee S, Worrell RA, Chen DY, Burgess WH, Linehan WM, Klausner RD . 1997 Proc. Natl. Acad. Sci. USA 94: 2156–2161

  • Pines J, Hunter T . 1990 Nature 346: 760–763

  • Poon RY, Toyoshima H, Hunter T . 1995 Mol. Biol. Cell 6: 1197–1213

  • Schoenfeld A, Davidowitz EJ, Burk RD . 1998 Proc. Natl. Acad. Sci. USA 95: 8817–8822

  • Shuin T, Kondo K, Torigoe S, Kishida T, Kubota Y, Hosaka M, Nagashima Y, Kitamura H, Latif F, Zbar B, Lerman MI, Yao M . 1994 Cancer Res. 54: 2852–2855

  • Soler C, Grangeasse C, Baggetto LG, Damour O . 1999 FEBS Lett. 442: 178–182

  • St Croix B, Sheehan C, Rak JW, Florenes VA, Slingerland JM, Kerbel RS . 1998 J. Cell. Biol. 142: 557–571

  • Talian JC, Olmsted JB, Goldman RD . 1983 J. Cell. Biol. 97: 1277–1282

  • Wada H, Yeh ET, Kamitani T . 1999 J. Biol. Chem. 274: 36025–36029

  • Watabe M, Nagafuchi A, Tsukita S, Takeichi M . 1994 J. Cell. Biol. 127: 247–256

  • Ye Y, Vasavada S, Kuzmin I, Stackhouse T, Zbar B, Williams BR . 1998 Int. J. Cancer 78: 62–69

Download references

Acknowledgements

We thank Dr William G Kaelin for 786-O cells and their VHL expressing subclones, and Dr Igor Kuzmin and Berton Zbar for UMRC-6 cells and their VHL expressing subclones, We thank Dr Teijiro Aso for anti elonginB antibody. We also thank Dr Kazuhiro Iwai for helpful discussion during the course of the work. This work was supported in part by Grants in Aid for Scientific Research from the Ministry of Education, Science, Sports and Culture of Japan and Grants from the Japan Society for the Promotion of Science 12219215 (to S Ohno) and 11160216 (to S Hirai). M Baba received support from the Yokohama Foundation for Advancement of Medical Science.

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Baba, M., Hirai, Si., Kawakami, S. et al. Tumor suppressor protein VHL is induced at high cell density and mediates contact inhibition of cell growth. Oncogene 20, 2727–2736 (2001). https://doi.org/10.1038/sj.onc.1204397

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1204397

Keywords

This article is cited by

Search

Quick links